Home > Insider Trading > Filing (0001787306-24-000081)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1787306	Arcutis Biotherapeutics Inc.	ARQT	Pharmaceutical Preparations (2834)	812974255

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1994805	Todd Larry Edwards	3027 Townsgate Road Suite 300 Westlake Village CA 91361	Svp Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-05-16	60,000	$0.00	148,000	No	4	A	Direct
Common Stock	Disposition	2024-05-17	7,640	$8.98	140,360	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Represents Restricted Stock Units ("RSUs"), initially granted on February 22, 2024, in which the shares were subject to a performance-based vesting condition, which was deemed satisfied on May 16, 2024 (the "Vesting Commencement Date"). Therefore, 50% of the shares vested on May 16, 2024 and the remaining 50% of the shares vest on May 16, 2025, subject to the Reporting Person's continued service with the Company through the applicable vesting date.
Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the RSUs, the shares were sold upon the vesting of the RSUs solely to cover applicable tax withholding.
The transaction was executed in multiple trades in prices ranging from $8.76 to $9.115, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.